A detailed history of Palogic Value Management, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Palogic Value Management, L.P. holds 8,825 shares of PFE stock, worth $221,772. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,825
Previous 8,825 -0.0%
Holding current value
$221,772
Previous $247 Million 3.43%
% of portfolio
0.1%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $320 - $375
10 Added 0.11%
8,825 $293 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $368,026 - $480,417
8,815 New
8,815 $452 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Palogic Value Management, L.P. Portfolio

Follow Palogic Value Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palogic Value Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Palogic Value Management, L.P. with notifications on news.